Beyond Single Platform Proteomics: Integrating Mass Spectrometry and NGS-powered Proteomics for Scale and Depth

Why combining complementary proteomics technologies delivers insight no single platform can achieve

Understanding complex biology at scale requires more than one proteomics approach. In this live webinar, discover how integrating Mass Spectrometry with NGS‑powered large‑scale proteomics enables both depth and population‑scale coverage, unlocking biological insight that single‑platform workflows cannot deliver.

Join Vincent Albrecht, PhD (Max Planck Institute of Biochemistry) as he shows how scalable, complementary proteomics technologies work together to capture dynamic proteome information across large cohorts, from high‑resolution molecular detail to broad population‑level profiling.
 

Agenda - 1-2pm BST | 2-3pm CET

• Introduction Into Proteomics At Scale
  Dr. Jan Rieger, Illumina, 10 min
• From Acute Response to Trained Phenotype: Multi-Platform Plasma Proteomics of Elite Athletes
  Dr. Vincent Albrecht, Max Planck Institute of Biochemistry, Germany, 25 min
• Live Q&A and panel discussion, 15 min
  All

What you’ll learn

In this webinar, you’ll see how combining proteomics platforms can:

• Reveal deeper biological insight through complementary Mass Spectrometry and NGS‑based proteomics
• Enable scalable plasma proteomics without compromising resolution
• Support population‑level studies while maintaining biological depth
• Bridge technology innovation with real‑world physiological research
   

About the speaker

Dr. Vincent Albrecht
Postdoctoral Researcher, Proteomics and Signal Transduction Max Planck Institute of Biochemistry

During his PhD, Vincent developed scalable workflows for deep plasma proteomics, including the PCA‑N method, enabling large cohort studies with dramatically reduced cost and sample requirements. His research focuses on applying these technologies across diverse clinical and physiological contexts, from large translational cohorts to the multi-platform study of exercise adaptation in elite athletes.

Vincent is an active member of the HUPO Human Plasma Proteome Project and the HUPO Early Career Researcher Committee.

M-EMEA-02216